Beijing Strong Biotechnologies Inc
SZSE:300406
Intrinsic Value
Beijing Strong Biotechnologies, Inc. engages in the research, development, manufacturing, and sales of in-vitro diagnostics (IVD) products. [ Read More ]
The intrinsic value of one
Beijing Strong Biotechnologies Inc
stock under the Base Case scenario is
26.55
CNY.
Compared to the current market price of 16.99 CNY,
Beijing Strong Biotechnologies Inc
is
Undervalued by 36%.
Beijing Strong Biotechnologies Inc's market capitalization is 10B CNY.
Beijing Strong Biotechnologies Inc stock price is 16.99 CNY.
Beijing Strong Biotechnologies Inc stock price (16.99 CNY) is 36% less than its Intrinsic Value (26.55 CNY).
Beijing Strong Biotechnologies Inc stock price (16.99 CNY) is 36% less than its DCF Value (26.52 CNY). Open DCF Valuation
Beijing Strong Biotechnologies Inc stock price (16.99 CNY) is 36% less than its Relative Value (26.59 CNY). Open Relative Valuation
Beijing Strong Biotechnologies Inc has upside potential of 29% compared to the average analyst price target.
Open Wall St Estimates
Beijing Strong Biotechnologies Inc has positive three-year average ROIC (Return on Invested Capital): 11%. The company is efficient at using invested capital to generate operating income.
Beijing Strong Biotechnologies Inc's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 13%.
Beijing Strong Biotechnologies Inc has positive three-year average ROE (Return on Equity): 12%. The company is efficient at transforming stockholders' equity into net income.
Beijing Strong Biotechnologies Inc's ROE (Return on Equity) for the past 12 months is positive and is equal to 15%.
Beijing Strong Biotechnologies Inc's ROIC (Return on Invested Capital) has increased in the last 3 years from 9% to 13%.
Beijing Strong Biotechnologies Inc's Revenue has grown by 15% over the past 12 months.
Beijing Strong Biotechnologies Inc has positive Net Debt. This means that the company has more debt (1B CNY) than cash and short-term investments (864m CNY).
Beijing Strong Biotechnologies Inc's ROE (Return on Equity) has increased in the last 3 years from 8% to 15%.
Beijing Strong Biotechnologies Inc's Revenue is forecast to grow at a rate of 19% per year over the next 3 years.
Beijing Strong Biotechnologies Inc has positive Net Income for the last twelve months.
Beijing Strong Biotechnologies Inc has positive Operating Income for the last twelve months.
Beijing Strong Biotechnologies Inc's Revenue has been growing by an exceptional 27% per year for the last 3 years.
Beijing Strong Biotechnologies Inc has positive Free Cash Flow for the last twelve months.
Beijing Strong Biotechnologies Inc has positive Gross Profit for the last twelve months.
Beijing Strong Biotechnologies Inc's D/E (Debt to Equity) is very low and is equal to 0.31.
Beijing Strong Biotechnologies Inc's long-term assets (5B CNY) exceed its long-term liabilties (1B CNY).
Beijing Strong Biotechnologies Inc's short-term assets (2B CNY) exceed its short-term liabilties (297m CNY).
Beijing Strong Biotechnologies Inc's Altman Z-Score is very high and is equal to 6.37.
Valuation Backtest
Beijing Strong Biotechnologies Inc
Run backtest to discover the historical profit from buying and selling
Beijing Strong Biotechnologies Inc
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Beijing Strong Biotechnologies Inc
Balance Sheet Decomposition
Beijing Strong Biotechnologies Inc
| Current Assets | 2.3B |
| Cash & Short-Term Investments | 863.8m |
| Receivables | 1.2B |
| Other Current Assets | 261.8m |
| Non-Current Assets | 2.8B |
| Long-Term Investments | 472.7m |
| PP&E | 555.2m |
| Intangibles | 1.7B |
| Other Non-Current Assets | 80.5m |
| Current Liabilities | 297.1m |
| Accounts Payable | 73.3m |
| Accrued Liabilities | 98.5m |
| Short-Term Debt | 10.9m |
| Other Current Liabilities | 114.5m |
| Non-Current Liabilities | 1.2B |
| Long-Term Debt | 1.1B |
| Other Non-Current Liabilities | 22.4m |
Earnings Waterfall
Beijing Strong Biotechnologies Inc
|
Revenue
|
1.7B
CNY
|
|
Cost of Revenue
|
-445m
CNY
|
|
Gross Profit
|
1.3B
CNY
|
|
Operating Expenses
|
-678.1m
CNY
|
|
Operating Income
|
618.5m
CNY
|
|
Other Expenses
|
-94.8m
CNY
|
|
Net Income
|
523.7m
CNY
|
Free Cash Flow Analysis
Beijing Strong Biotechnologies Inc
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Beijing Strong Biotechnologies Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Beijing Strong Biotechnologies Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Beijing Strong Biotechnologies Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
Beijing Strong Biotechnologies Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Beijing Strong Biotechnologies Inc
According to Wall Street analysts, the average 1-year price target for
Beijing Strong Biotechnologies Inc
is 22 CNY
.
Shareholder Return
Price
Beijing Strong Biotechnologies Inc
| Average Annual Return | 3.69% |
| Standard Deviation of Annual Returns | 34.65% |
| Max Drawdown | -47% |
| Market Capitalization | 10B CNY |
| Shares Outstanding | 588 445 404 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Beijing Strong Biotechnologies Inc
Country
Industry
Market Cap
Dividend Yield
Description
Beijing Strong Biotechnologies, Inc. engages in the research, development, manufacturing, and sales of in-vitro diagnostics (IVD) products. The company is headquartered in Beijing, Beijing and currently employs 967 full-time employees. The company went IPO on 2014-10-30. The Company’s in vitro diagnostic reagents are mainly used in liver, renal, blood fat, glycometabolism and other fields. The firm is also engaged in the manufacture and sales of in vitro diagnostic equipment and the leasing of equipment. The firm operates businesses in domestic and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Beijing Strong Biotechnologies Inc
stock under the Base Case scenario is
26.55
CNY.
Compared to the current market price of 16.99 CNY,
Beijing Strong Biotechnologies Inc
is
Undervalued by 36%.
You don't have any saved screeners yet
